Changing therapeutic paradigms for intestinal health: Diet as a therapeutic strategy in Gastroenterology.

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Irritable bowel syndrome (IBS) affects 1 in 7 adults in Australia. IBS symptoms include abdominal pain, bloating and wind. My team has shown that fermentable short chain carbohydrates (FODMAPs) present in many foods are responsible for triggering these symptoms. The Low FODMAP diet is now being adopted worldwide as first-line management therapy for IBS. The delivery of this research worldwide has been possible through the use of a smartphone app: The Monash Uni Low FODMAP diet.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2022

Funding Scheme: Research Fellowships

Funding Amount: $640,210.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Clinical and Sports Nutrition

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

carbohydrates | dietary intervention | gastroenterology | irritable bowel syndrome (IBS) | nutritional therapy